Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Share:
Related UNH
'Full Potential' For UnitedHealth
The Market In 5 Minutes: OPEC, Earnings And Trump's Cabinet
UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump (Investor's Business Daily)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

DateFirmActionFromTo
Nov 2016OppenheimerMaintainsOutperform
Nov 2016JP MorganMaintainsOverweight
Nov 2016Credit SuisseMaintainsOutperform

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

View Comments and Join the Discussion!